Giuseppe Musumeci

Interventional cardiologist / Cardiologist
Mauritian Umberto I Hospital - Torino, Italy

Latest contributions

Treatment and prognostic stratification of ACS patients with cardiogenic shock

21 May 2025 – From EuroPCR 2025

This session focuses on treatment and prognostic stratification in ACS patients complicated by cardiogenic shock. Topics include mechanical CPR device performance, SCAI shock grade dynamics, hemorrhagic event predictors, ECMO-related strategies, and evaluation of BCIS conveyance algorithms for out-of-hospital cardiac arrest.

Treatment and prognostic stratification of ACS patients with cardiogenic shock

TAVI: managing acute procedural complications

16 May 2024 – From EuroPCR 2024

From deep implantation challenges to embolization and iatrogenic dissections, each presentation highlights techniques for addressing critical procedural hurdles. Topics include bailout strategies, managing embolized valves, complex second valve placements, and handling unusual TAVR scenarios, offering insights on navigating complications and ensuring procedural safety.

TAVI: managing acute procedural complications

When imaging guides PCI complications management

15 May 2024 – From EuroPCR 2024

This session features selected EuroPCR 2024 Clinical Case submissions highlighting the role of imaging in managing complications during percutaneous coronary interventions (PCI). Experts will present and discuss cases involving recurrent acute myocardial infarction, stent crumpling, and other unexpected complications, demonstrating how the use of various imaging...

When imaging guides PCI complications management

When using left ventricular support during PCI

14 May 2024 – From EuroPCR 2024

This session will feature a series of selected clinical case submissions from EuroPCR 2024, focusing on the use of left ventricular support devices, such as the Impella, during percutaneous coronary interventions. Attendees will have the opportunity to explore various scenarios, including the management of Impella impaction,...

When using left ventricular support during PCI

Valve-in-valve procedures - Part 1

18 May 2023 – From EuroPCR 2023

Discover the innovative solutions offered by valve-in-valve procedures in this session: witness the successful application of this technique in a patient with heparin-induced thrombocytopenia, explore a captivating case series showcasing valve-in-valve TAVI in failed Perceval bioprostheses, delve into the complexities of TAVR in SAVR in IIIb type...

Valve-in-valve procedures - Part 1

Intervention in end stage heart failure: LVAD complications and pressure control

19 May 2022 – From EuroPCR 2022

Prevention and management of periprocedural TAVI complications

23 May 2019 – From EuroPCR 2019

Consult this session to discover challenging clinical cases involving periprocedural TAVI complications frequently encountered in clinical practice, and to learn more about how to plan an optimal TAVI strategy in high-risk patients.

Prevention and management of periprocedural TAVI complications

Trials and registries - Stents and procedural techniques for the treatment of high-risk patients

23 May 2019 – From EuroPCR 2019

Consult this session to learn all about the latest trials and registries regarding stents and procedural techniques for the treatment of high-risk patients: EuRo4C, PREPARE-CALC, CART, and more!

New trials in coronary imaging and physiology

23 May 2019 – From EuroPCR 2019

Consult this session to learn all about the new trials and studies in coronary imaging and physiology: FFR-Search, ROCK II, HAWKEYE, and more!

New trials in coronary imaging and physiology

Management of severe complications of PCI

22 May 2019 – From EuroPCR 2019

Consult this session to learn more about tools and techniques to efficiently manage severe complications of PCI, such as an intracoronary stent embolisation, a trapped coronary stent balloon, a coronary perforation, and more!

Management of severe complications of PCI

Bridging the gap of oral P2Y12 inhibition for PCI with cangrelor: what does the new data tell us?

22 May 2019 – From EuroPCR 2019

Consult this session to learn through studies and clinical cases more about contemporary pharmacological strategies with intravenous antiplatelet therapy in PCI for STEMI, NSTEMI and complex stable coronary artery disease patients.

Bridging the gap of oral P2Y12 inhibition for PCI with cangrelor: what does the new data tell us?